These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34489968)

  • 1. Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment.
    Houben T; Yadati T; de Kruijf R; Gijbels MJJ; Luiken JJFP; van Zandvoort M; Kapsokalyvas D; Lütjohann D; Westerterp M; Plat J; Leake D; Shiri-Sverdlov R
    Front Immunol; 2021; 12():716357. PubMed ID: 34489968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.
    Bieghs V; Hendrikx T; van Gorp PJ; Verheyen F; Guichot YD; Walenbergh SM; Jeurissen ML; Gijbels M; Rensen SS; Bast A; Plat J; Kalhan SC; Koek GH; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
    Gastroenterology; 2013 Jan; 144(1):167-178.e1. PubMed ID: 23041327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice.
    Walenbergh SM; Houben T; Hendrikx T; Jeurissen ML; van Gorp PJ; Vaes N; Olde Damink SW; Verheyen F; Koek GH; Lütjohann D; Grebe A; Latz E; Shiri-Sverdlov R
    Int J Mol Sci; 2015 Sep; 16(9):21056-69. PubMed ID: 26404254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.
    Taylor AM; Liu B; Mari Y; Liu B; Repa JJ
    J Lipid Res; 2012 Nov; 53(11):2331-42. PubMed ID: 22892156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    Jeurissen ML; Walenbergh SM; Houben T; Hendrikx T; Li J; Oligschlaeger Y; van Gorp PJ; Gijbels MJ; Bitorina A; Nessel I; Radtke F; Vooijs M; Theys J; Shiri-Sverdlov R
    PLoS One; 2016; 11(11):e0167199. PubMed ID: 27898698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
    Gruben N; Funke A; Kloosterhuis NJ; Schreurs M; Sheedfar F; Havinga R; Houten SM; Shiri-Sverdlov R; van de Sluis B; Kuivenhoven JA; Koonen DP; Hofker MH
    J Diabetes Res; 2015; 2015():956854. PubMed ID: 25815343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
    Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
    Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Lxrα reduces atherosclerosis in Ldlr
    Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
    Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
    Bieghs V; Verheyen F; van Gorp PJ; Hendrikx T; Wouters K; Lütjohann D; Gijbels MJ; Febbraio M; Binder CJ; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2012; 7(3):e34378. PubMed ID: 22470565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
    van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
    PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
    Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-HEPE-Concentrated Materials from Pacific Krill Improve Plasma Cholesterol Levels and Hepatic Steatosis in High Cholesterol Diet-Fed Low-Density Lipoprotein (LDL) Receptor-Deficient Mice.
    Saito M; Ishida N; Yamada H; Ibi M; Hirose M
    Biol Pharm Bull; 2020; 43(6):919-924. PubMed ID: 32475913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hyperalgesic and anti-inflammatory effects of citral with β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes in animal models.
    Campos CA; Lima BS; Trindade GGG; Souza EPBSS; Mota DSA; Heimfarth L; Quintans JSS; Quintans-Júnior LJ; Sussuchi EM; Sarmento VHV; Carvalho FMS; Marreto RN; Costa RMR; Nunes RS; Araújo AAS; Shanmugam S; Thangaraj P
    Life Sci; 2019 Jul; 229():139-148. PubMed ID: 31085246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.
    Peake KB; Vance JE
    J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
    Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic Npc1 mutation shifts gut microbiota composition in Ldlr
    Houben T; Penders J; Oligschlaeger Y; Dos Reis IAM; Bonder MJ; Koonen DP; Fu J; Hofker MH; Shiri-Sverdlov R
    Sci Rep; 2019 Oct; 9(1):14956. PubMed ID: 31628414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
    Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP
    Am J Pathol; 2012 Oct; 181(4):1287-95. PubMed ID: 22841818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships of cholesterol mobilization from the endo-lysosome compartment of NPC1-deficient human cells by β-CD polyrotaxanes.
    Samaddar S; Bose D; Loren BP; Skulsky JL; Ilnytska O; Struzik ZJ; Storch J; Thompson DH
    PLoS One; 2022; 17(12):e0268613. PubMed ID: 36584173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.